Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan

INTRODUCTION: Dolutegravir (DTG), a novel HIV-integrase strand transfer inhibitor (INSTI), is usually used with multiple antiretrovirals (ARVs) for treatment of HIV. DTG is now approved as Tivicay tablets in over 120 countries and Triumeq combination tablets (DTG/abacavir [ABC]/lamivudine [3TC]) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hongo, Haruyuki, Nagao, Takako, Nakamura, Kyoko, Kitaichi, Tomomi, Maeno, Yuko, Tokunaga, Teruhisa, Fukuda, Akiko, Koga, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342375/
https://www.ncbi.nlm.nih.gov/pubmed/34275116
http://dx.doi.org/10.1007/s12325-021-01842-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342375/
https://www.ncbi.nlm.nih.gov/pubmed/34275116
http://dx.doi.org/10.1007/s12325-021-01842-3

Ejemplares similares